{"id":"https://openalex.org/W4400007994","doi":"https://doi.org/10.1007/s40744-024-00684-z","title":"Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis","display_name":"Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis","publication_year":2024,"publication_date":"2024-06-25","ids":{"openalex":"https://openalex.org/W4400007994","doi":"https://doi.org/10.1007/s40744-024-00684-z","pmid":"https://pubmed.ncbi.nlm.nih.gov/38916823","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11265043"},"language":"en","primary_location":{"id":"doi:10.1007/s40744-024-00684-z","doi":"https://doi.org/10.1007/s40744-024-00684-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40744-024-00684-z","pdf_url":null,"source":{"id":"https://openalex.org/S4210196954","display_name":"Rheumatology and Therapy","issn_l":"2198-6576","issn":["2198-6576","2198-6584"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1007/s40744-024-00684-z","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069979151","display_name":"Walter P. Maksymowych","orcid":"https://orcid.org/0000-0002-1291-1755","observed_orcids":["https://orcid.org/0000-0002-1291-1755","https://orcid.org/0000-0002-0121-5543"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Walter P. Maksymowych","raw_affiliation_strings":["Department of Medicine, University of Alberta, Edmonton, AB, Canada. walter.maksymowych@ualberta.ca","Department of Medicine, University of Alberta, Edmonton, AB, Canada"],"raw_orcid":"https://orcid.org/0000-0002-1291-1755","affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Alberta, Edmonton, AB, Canada. walter.maksymowych@ualberta.ca","institution_ids":["https://openalex.org/I154425047"]},{"raw_affiliation_string":"Department of Medicine, University of Alberta, Edmonton, AB, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071628619","display_name":"Howard H. Z. Thom","orcid":"https://orcid.org/0000-0001-8576-5552","observed_orcids":["https://orcid.org/0000-0001-8576-5552"]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Howard Thom","raw_affiliation_strings":["Clifton Insight, Bristol, UK","University of Bristol, Bristol, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clifton Insight, Bristol, UK","institution_ids":[]},{"raw_affiliation_string":"University of Bristol, Bristol, UK","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055716461","display_name":"Michael Frank M\u00f8rup","orcid":"https://orcid.org/0000-0002-1987-1223","observed_orcids":["https://orcid.org/0000-0002-1987-1223"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael F. M\u00f8rup","raw_affiliation_strings":["UCB Pharma, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Copenhagen, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063754167","display_name":"V. Taieb","orcid":"https://orcid.org/0000-0003-0655-8630","observed_orcids":["https://orcid.org/0000-0003-0655-8630"]},"institutions":[{"id":"https://openalex.org/I4210103390","display_name":"UCB Pharma (France)","ror":"https://ror.org/01n6t9x28","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210103390","https://openalex.org/I85722119"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Vanessa Taieb","raw_affiliation_strings":["UCB Pharma, Colombes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Colombes, France","institution_ids":["https://openalex.org/I4210103390"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019982183","display_name":"Damon Willems","orcid":"https://orcid.org/0000-0001-8263-4047","observed_orcids":["https://orcid.org/0000-0001-8263-4047"]},"institutions":[{"id":"https://openalex.org/I85722119","display_name":"UCB Pharma (Belgium)","ror":"https://ror.org/01n029866","country_code":"BE","type":"company","lineage":["https://openalex.org/I85722119"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Damon Willems","raw_affiliation_strings":["UCB Pharma, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Brussels, Belgium","institution_ids":["https://openalex.org/I85722119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087345814","display_name":"Nikos Lyris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134054","display_name":"UCB Pharma (United Kingdom)","ror":"https://ror.org/03428qp74","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210134054","https://openalex.org/I85722119"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nikos Lyris","raw_affiliation_strings":["UCB Pharma, Slough, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Slough, UK","institution_ids":["https://openalex.org/I4210134054"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033667268","display_name":"Karl Gaffney","orcid":"https://orcid.org/0000-0002-7863-9176","observed_orcids":["https://orcid.org/0000-0002-7863-9176"]},"institutions":[{"id":"https://openalex.org/I2799472390","display_name":"Norfolk and Norwich University Hospital","ror":"https://ror.org/021zm6p18","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799472390","https://openalex.org/I2800371493"]},{"id":"https://openalex.org/I2800371493","display_name":"Norfolk and Norwich University Hospitals NHS Foundation Trust","ror":"https://ror.org/01wspv808","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800371493"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Karl Gaffney","raw_affiliation_strings":["Norfolk and Norwich University Hospital NHS Trust, Norfolk, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Norfolk and Norwich University Hospital NHS Trust, Norfolk, UK","institution_ids":["https://openalex.org/I2799472390","https://openalex.org/I2800371493"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5069979151"],"corresponding_institution_ids":["https://openalex.org/I154425047"],"apc_list":{"value":6850,"currency":"USD","value_usd":6850},"apc_paid":{"value":6850,"currency":"USD","value_usd":6850},"fwci":2.2192,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.86699663,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"11","issue":"4","first_page":"1023","last_page":"1041"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bimekizumab","display_name":"bimekizumab","score":0.8360000252723694},{"id":"https://openalex.org/keywords/secukinumab","display_name":"secukinumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ixekizumab","display_name":"ixekizumab","score":1.0},{"id":"https://openalex.org/keywords/radiographic-axial-spondyloarthritis","display_name":"radiographic axial spondyloarthritis","score":0.9300000071525574},{"id":"https://openalex.org/keywords/ankylosing-spondylitis","display_name":"ankylosing spondylitis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/il-17a-inhibitor","display_name":"IL-17A inhibitor","score":0.781000018119812},{"id":"https://openalex.org/keywords/il-17f","display_name":"IL-17F","score":0.8330000042915344},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.6539999842643738},{"id":"https://openalex.org/keywords/matching-adjusted-indirect-comparison","display_name":"matching-adjusted indirect comparison","score":0.8349999785423279},{"id":"https://openalex.org/keywords/propensity-score-weighting","display_name":"propensity score weighting","score":0.7400000095367432},{"id":"https://openalex.org/keywords/individual-patient-data","display_name":"individual patient data","score":0.6489999890327454},{"id":"https://openalex.org/keywords/coast","display_name":"coast","score":0.9470000267028809}],"concepts":[{"id":"https://openalex.org/C2779786854","wikidata":"https://www.wikidata.org/wiki/Q7444755","display_name":"Secukinumab","level":4,"score":0.9793511629104614},{"id":"https://openalex.org/C2779745271","wikidata":"https://www.wikidata.org/wiki/Q13574436","display_name":"Ixekizumab","level":5,"score":0.9381424188613892},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7240594625473022},{"id":"https://openalex.org/C2776213234","wikidata":"https://www.wikidata.org/wiki/Q28867094","display_name":"Axial spondyloarthritis","level":4,"score":0.6930060982704163},{"id":"https://openalex.org/C165064840","wikidata":"https://www.wikidata.org/wiki/Q1321061","display_name":"Matching (statistics)","level":2,"score":0.5753016471862793},{"id":"https://openalex.org/C36454342","wikidata":"https://www.wikidata.org/wiki/Q245341","display_name":"Radiography","level":2,"score":0.4252469539642334},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2873840928077698},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.1631164252758026},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.09902533888816833},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.060821473598480225},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.05999338626861572},{"id":"https://openalex.org/C2778579456","wikidata":"https://www.wikidata.org/wiki/Q2213687","display_name":"Sacroiliitis","level":3,"score":0.0}],"mesh":[],"locations_count":7,"locations":[{"id":"doi:10.1007/s40744-024-00684-z","doi":"https://doi.org/10.1007/s40744-024-00684-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40744-024-00684-z","pdf_url":null,"source":{"id":"https://openalex.org/S4210196954","display_name":"Rheumatology and Therapy","issn_l":"2198-6576","issn":["2198-6576","2198-6584"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11265043","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11265043","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11265043/pdf/40744_2024_Article_684.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatol Ther","raw_type":"Text"},{"id":"pmid:38916823","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38916823","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:research-information.bris.ac.uk:openaire/a49258be-67f4-4c18-8867-f829bfb0256f","doi":null,"is_oa":true,"landing_page_url":"https://research-information.bris.ac.uk/en/publications/a49258be-67f4-4c18-8867-f829bfb0256f","pdf_url":null,"source":{"id":"https://openalex.org/S7407055359","display_name":"Explore Bristol Research","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Maksymowych, W P, Thom, H H Z, Morup, M, Taieb, V, Willems, D, Lyris, N & Gaffney, K 2024, 'Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis', Rheumatology and Therapy, vol. 11, no. 4, pp. 1023-1041. https://doi.org/10.1007/s40744-024-00684-z","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:ueaeprints.uea.ac.uk:96410","doi":null,"is_oa":true,"landing_page_url":"https://ueaeprints.uea.ac.uk/id/eprint/96410/1/Maksymowych_etal_2024_RheumatologyAndTherapy.pdf","pdf_url":"https://ueaeprints.uea.ac.uk/id/eprint/96410/1/Maksymowych_etal_2024_RheumatologyAndTherapy.pdf","source":{"id":"https://openalex.org/S4306400384","display_name":"UEA Digital Repository (University of East Anglia)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1118541","host_organization_name":"University of East Anglia","host_organization_lineage":["https://openalex.org/I1118541"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:doaj.org/article:4b878f98b5e34d09a94b0e709d45235c","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/4b878f98b5e34d09a94b0e709d45235c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Rheumatology and Therapy, Vol 11, Iss 4, Pp 1023-1041 (2024)","raw_type":"article"},{"id":"pmh:oai:research-information.bris.ac.uk:openaire_cris_publications/a49258be-67f4-4c18-8867-f829bfb0256f","doi":null,"is_oa":true,"landing_page_url":"https://research-information.bris.ac.uk/en/publications/a49258be-67f4-4c18-8867-f829bfb0256f","pdf_url":null,"source":{"id":"https://openalex.org/S4306400895","display_name":"Bristol Research (University of Bristol)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I36234482","host_organization_name":"University of Bristol","host_organization_lineage":["https://openalex.org/I36234482"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Maksymowych, W P, Thom, H H Z, Morup, M, Taieb, V, Willems, D, Lyris, N & Gaffney, K 2024, 'Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis', Rheumatology and Therapy, vol. 11, no. 4, pp. 1023-1041. https://doi.org/10.1007/s40744-024-00684-z","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1007/s40744-024-00684-z","doi":"https://doi.org/10.1007/s40744-024-00684-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40744-024-00684-z","pdf_url":null,"source":{"id":"https://openalex.org/S4210196954","display_name":"Rheumatology and Therapy","issn_l":"2198-6576","issn":["2198-6576","2198-6584"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320337846","display_name":"UCB Pharma","ror":"https://ror.org/01n029866"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400007994.pdf","grobid_xml":"https://content.openalex.org/works/W4400007994.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1809273654","https://openalex.org/W1968940806","https://openalex.org/W2077615804","https://openalex.org/W2092901728","https://openalex.org/W2278932593","https://openalex.org/W2554484156","https://openalex.org/W2564945411","https://openalex.org/W2591276563","https://openalex.org/W2760274177","https://openalex.org/W2780640950","https://openalex.org/W2787359140","https://openalex.org/W2885214565","https://openalex.org/W2898749318","https://openalex.org/W2965192984","https://openalex.org/W2969598066","https://openalex.org/W2982785161","https://openalex.org/W2993436820","https://openalex.org/W3014565220","https://openalex.org/W3023135477","https://openalex.org/W3047978234","https://openalex.org/W3086596347","https://openalex.org/W3118615836","https://openalex.org/W3199751269","https://openalex.org/W4200322391","https://openalex.org/W4200568789","https://openalex.org/W4229001511","https://openalex.org/W4235489476","https://openalex.org/W4285393265","https://openalex.org/W4307091386","https://openalex.org/W4317103607","https://openalex.org/W4380150789","https://openalex.org/W4380151365","https://openalex.org/W4387343815","https://openalex.org/W4388557119","https://openalex.org/W4390128318","https://openalex.org/W4399481849"],"related_works":["https://openalex.org/W4390126595","https://openalex.org/W4390128438","https://openalex.org/W4388557119","https://openalex.org/W4380150789","https://openalex.org/W4317103607","https://openalex.org/W4319596458","https://openalex.org/W4395084837","https://openalex.org/W4366832057","https://openalex.org/W4409899137","https://openalex.org/W6980254352"],"abstract_inverted_index":{"INTRODUCTION:":[0],"A":[1],"previous":[2,271],"network":[3],"meta-analysis":[4],"established":[5],"16-week":[6],"relative":[7,47],"efficacy":[8,48,129,167,195,230,245,251,288,305],"with":[9,25,146,169,270,277,307],"bimekizumab,":[10],"an":[11],"inhibitor":[12,114],"of":[13,49,163,248,268,284],"interleukin":[14],"(IL)-17F":[15],"in":[16,165,193,304],"addition":[17],"to":[18,71,264],"IL-17A,":[19],"versus":[20,51,171,211,289,309],"other":[21],"treatments":[22],"for":[23,88,141,227,246,301],"patients":[24,99,158,269],"radiographic":[26],"axial":[27],"spondyloarthritis":[28],"(r-axSpA;":[29],"i.e.,":[30],"ankylosing":[31],"spondylitis),":[32],"including":[33],"the":[34,132,249,265,318],"IL-17A":[35],"inhibitors":[36],"secukinumab":[37,52,172,200,290],"and":[38,53,93,120,123,127,199],"ixekizumab.":[39,54],"This":[40],"matching-adjusted":[41],"indirect":[42],"comparison":[43],"(MAIC)":[44],"assessed":[45],"52-week":[46,128,194],"bimekizumab":[50,170,198,240,278,294,308],"METHODS:":[55],"Individual":[56],"patient":[57],"data":[58,74],"from":[59,75,131],"BE":[60,96],"MOBILE":[61,97],"2":[62,98],"(bimekizumab":[63],"160":[64],"mg;":[65,85],"N":[66],"=":[67,184,190,208,219,237],"220)":[68],"were":[69,100,205,225,256,313],"matched":[70],"pooled":[72],"summary":[73],"MEASURE":[76,81],"1/2/3/4":[77],"(secukinumab":[78,83],"150":[79,173,291],"mg),":[80],"3":[82],"300":[84,201],"escalated":[86],"dose":[87,203],"inadequate":[89],"responders),":[90],"COAST-V":[91],"(ixekizumab)":[92],"COAST-V/-W":[94],"(ixekizumab).":[95],"reweighted":[101],"using":[102],"propensity":[103],"score":[104],"weights":[105],"based":[106],"on":[107,317],"age,":[108],"sex,":[109],"ethnicity,":[110],"tumor":[111],"necrosis":[112],"factor":[113],"(TNFi)":[115],"exposure,":[116],"weight,":[117],"baseline":[118,124],"ASDAS":[119],"BASFI":[121],"(secukinumab)":[122],"BASDAI":[125],"(ixekizumab),":[126],"outcomes":[130,168,196,306],"trial":[133],"recalculated.":[134],"Odds":[135],"ratios":[136],"(OR)":[137],"or":[138],"mean":[139],"difference":[140],"unanchored":[142],"comparisons":[143,215,234],"are":[144],"reported":[145],"95%":[147],"confidence":[148],"intervals":[149],"(CI).":[150],"RESULTS:":[151],"At":[152],"week":[153],"52,":[154],"MAIC":[155],"demonstrated":[156],"that":[157,223],"may":[159,241,279,295],"have":[160,242,280],"higher":[161,243,282],"likelihood":[162,283],"improvement":[164],"key":[166,229],"mg":[174,202,214,312],"(e.g.,":[175],"ASAS40:":[176],"[OR":[177],"(95%":[178],"CI):":[179],"1.48":[180],"(1.05,":[181],"2.10);":[182],"p":[183],"0.026];":[185],"effective":[186],"sample":[187],"size":[188],"[ESS]":[189],"177).":[191],"Differences":[192,303],"between":[197],"escalation":[204],"non-significant":[206,226],"(ESS":[207],"120).":[209],"Bimekizumab":[210],"ixekizumab":[212,233,254,310],"80":[213,311],"(COAST-V":[216],"only;":[217],"ESS":[218,236],"84)":[220],"also":[221],"suggested":[222,239],"differences":[224],"most":[228],"outcomes.":[231],"Other":[232],"(COAST-V/-W;":[235],"45)":[238],"comparative":[244],"many":[247],"same":[250],"outcomes,":[252],"however":[253],"analyses":[255],"limited":[257],"by":[258],"poor":[259],"population":[260],"overlap,":[261],"likely":[262],"due":[263],"greater":[266],"proportion":[267],"TNFi":[272],"exposure.":[273],"CONCLUSIONS:":[274],"Patients":[275],"treated":[276],"a":[281,297],"achieving":[285],"improved":[286],"longer-term":[287],"mg,":[292],"suggesting":[293],"be":[296],"favorable":[298],"therapeutic":[299],"option":[300],"r-axSpA.":[302],"mostly":[314],"non-significant,":[315],"depending":[316],"populations":[319],"considered.":[320]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2024-06-26T00:00:00"}